Sign in

CIK 0001867096

  • Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
871082097
Phone
+1 844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
  1. 3 Insider Initial Statement of Ownership
  2. 4 Planned sale McCulloch Kevin sold 90,000 shares at $8.03 ($722,511)
  3. 4 Planned sale Hecht Beth sold 16,666 shares at $8.03 ($133,860)
  4. 4 Grant or award Director acquired 24,193 shares (grant or award)
  5. 4 Planned sale Director sold 15,500 shares at $5.90 ($91,433)
  6. 4 Planned sale Director sold 20,000 shares at $6.09 ($121,886)
  7. 4 Planned sale Director sold 16,000 shares at $6.09 ($97,507)
  8. 4 Planned sale Director sold 15,000 shares at $6.09 ($91,422)
  9. 4 Grant or award Director acquired 24,193 shares (grant or award)
  10. 4 Planned sale Hecht Beth sold 16,667 shares at $6.06 ($100,982)
  11. 4 Planned sale Hecht Beth sold 16,667 shares at $6.23 ($103,805)
  12. 4 Planned sale Hecht Beth sold 16,667 shares at $5.99 ($99,859)
  13. 4 Planned sale Director sold 10,834 shares at $5.54 ($60,036)
  14. 4 Exercise or conversion McCulloch Kevin acquired 48,898 shares (option exercise)
  15. 4 Exercise or conversion Pieper Steven acquired 41,927 shares (option exercise)
  16. 4 Planned sale Hecht Beth sold 16,667 shares at an average $6.25 ($104,086)
  17. 4 Shares withheld for taxes Nguyen Anh Tu gave up 29,300 shares (to pay taxes)
  18. 4 Shares withheld for taxes Shannon John Patrick Jr gave up 340,505 shares (to pay taxes)
  19. 4 Shares withheld for taxes McCulloch Kevin gave up 126,062 shares (to pay taxes)
  20. 4 Shares withheld for taxes Pieper Steven gave up 205,534 shares (to pay taxes)

Page 2 of 9 · 178 filings